Literature DB >> 20809888

HR MAS MR spectroscopy in metabolic characterization of cancer.

Siver Moestue1, Beathe Sitter, Tone Frost Bathen, May-Britt Tessem, Ingrid Susann Gribbestad.   

Abstract

One of the central hallmarks of cancer is the rapid and infinite cellular proliferation. In order to cope with increased requirement for building blocks and energy, cancer cells develop abnormal metabolic properties. Detailed assessment of cancer cell metabolism can provide biological information for use in both drug discovery and development of personalized cancer therapy. Analysis of intact tissue using high resolution magic angle spinning (HR MAS) magnetic resonance spectroscopy (MRS) gives qualitative and quantitative metabolite measures with minimal sample preparation. Multivariate statistical methods are important tools for analysis of complex MR data and have in recent years been used for analysis of HR MAS data from intact tissue. HR MAS analysis of intact tissue allows combination of metabolomic data with genomic or proteomic data, and can therefore be used both for exploring the molecular biology of cancer and for clinical improvements in cancer diagnostics, prognostics and treatment planning. In this review, the basic concepts of HR MAS are presented, and its use in characterisation of cancer metabolism is discussed with specific focus on selected pathways such as choline metabolism and glycolysis. The use of HR MAS in analysis of amino acids and lipid metabolism in cancer is also reviewed. Finally, the expected role of HR-MAS in metabolic characterisation in the near future is discussed.

Entities:  

Mesh:

Year:  2011        PMID: 20809888     DOI: 10.2174/156802611793611869

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  40 in total

1.  Selective galactose culture condition reveals distinct metabolic signatures in pyruvate dehydrogenase and complex I deficient human skin fibroblasts.

Authors:  Damian Hertig; Andrea Felser; Gaëlle Diserens; Sandra Kurth; Peter Vermathen; Jean-Marc Nuoffer
Journal:  Metabolomics       Date:  2019-02-28       Impact factor: 4.290

Review 2.  NMR-based metabolomics studies of human prostate cancer tissue.

Authors:  Ana Rita Lima; Joana Pinto; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho
Journal:  Metabolomics       Date:  2018-06-18       Impact factor: 4.290

Review 3.  Analysis of bacterial biofilms using NMR-based metabolomics.

Authors:  Bo Zhang; Robert Powers
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

Review 4.  Introduction to metabolomics and its applications in ophthalmology.

Authors:  S Z Tan; P Begley; G Mullard; K A Hollywood; P N Bishop
Journal:  Eye (Lond)       Date:  2016-03-18       Impact factor: 3.775

Review 5.  Applications of NMR spectroscopy to systems biochemistry.

Authors:  Teresa W-M Fan; Andrew N Lane
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2016-02-06       Impact factor: 9.795

Review 6.  Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.

Authors:  Kanchan Sonkar; Vinay Ayyappan; Caitlin M Tressler; Oluwatobi Adelaja; Ruoqing Cai; Menglin Cheng; Kristine Glunde
Journal:  NMR Biomed       Date:  2019-06-11       Impact factor: 4.044

7.  2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping.

Authors:  Morteza Esmaeili; Riyas Vettukattil; Tone Frost Bathen
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

8.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

9.  High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance of Intact Zebrafish Embryos Detects Metabolic Changes Following Exposure to Teratogenic Polymethoxyalkenes from Algae.

Authors:  John P Berry; Upasana Roy; Asha Jaja-Chimedza; Kristel Sanchez; Joerg Matysik; A Alia
Journal:  Zebrafish       Date:  2016-06-27       Impact factor: 1.985

Review 10.  Toward new biomarkers of cardiometabolic diseases.

Authors:  Lee D Roberts; Robert E Gerszten
Journal:  Cell Metab       Date:  2013-06-13       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.